Kalish Jennifer M, Boodhansingh Kara E, Bhatti Tricia R, Ganguly Arupa, Conlin Laura K, Becker Susan A, Givler Stephanie, Mighion Lindsey, Palladino Andrew A, Adzick N Scott, De León Diva D, Stanley Charles A, Deardorff Matthew A
Division of Human Genetics, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA Department of Pediatrics, The Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Division of Endocrinology, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
J Med Genet. 2016 Jan;53(1):53-61. doi: 10.1136/jmedgenet-2015-103394. Epub 2015 Nov 6.
Congenital hyperinsulinism (HI) can have monogenic or syndromic causes. Although HI has long been recognised to be common in children with Beckwith-Wiedemann syndrome (BWS), the underlying mechanism is not known.
We characterised the clinical features of children with both HI and BWS/11p overgrowth spectrum, evaluated the contribution of KATP channel mutations to the molecular pathogenesis of their HI and assessed molecular pathogenesis associated with features of BWS.
We identified 28 children with HI and BWS/11p overgrowth from 1997 to 2014. Mosaic paternal uniparental isodisomy for chromosome 11p (pUPD11p) was noted in 26/28 cases. Most were refractory to diazoxide treatment and half required subtotal pancreatectomies. Patients displayed a wide range of clinical features from classical BWS to only mild hemihypertrophy (11p overgrowth spectrum). Four of the cases had a paternally transmitted KATP mutation and had a much more severe HI course than patients with pUPD11p alone.
We found that patients with pUPD11p-associated HI have a persistent and severe HI phenotype compared with transient hypoglycaemia of BWS/11p overgrowth patients caused by other aetiologies. Testing for pUPD11p should be considered in all patients with persistent congenital HI, especially for those without an identified HI gene mutation.
先天性高胰岛素血症(HI)可由单基因或综合征性病因引起。尽管长期以来人们都认识到HI在患有贝克威思-维德曼综合征(BWS)的儿童中很常见,但其潜在机制尚不清楚。
我们对患有HI和BWS/11p过度生长谱系的儿童的临床特征进行了描述,评估了KATP通道突变对其HI分子发病机制的作用,并评估了与BWS特征相关的分子发病机制。
我们在1997年至2014年间确定了28例患有HI和BWS/11p过度生长的儿童。26/28例患儿存在11号染色体p臂单亲二倍体(pUPD11p)。大多数患儿对二氮嗪治疗无效,半数患儿需要进行胰腺次全切除术。患者表现出从典型BWS到仅轻度半侧肥大(11p过度生长谱系)的广泛临床特征。其中4例患儿存在父系遗传的KATP突变,其HI病程比仅患有pUPD11p的患者严重得多。
我们发现,与由其他病因引起的BWS/11p过度生长患者的短暂低血糖相比,患有pUPD11p相关HI的患者具有持续且严重的HI表型。对于所有持续性先天性HI患者,尤其是那些未鉴定出HI基因突变的患者,应考虑检测pUPD11p。